Regulators Approve Pepco, Exelon Merger
Regulators in Washington have just announced that Exelon's proposed $6.8 billion acquisition of Pepco was approved.
All Work
Chris Lange
What to Expect From Finish Line Earnings
Finish Line is scheduled to report fiscal fourth-quarter financial results before the markets open on Thursday.
Credit Suisse Accelerates Restructuring Plan
Credit Suisse will be cutting 2,000 jobs in its Global Markets unit, increasing the total job cuts announced thus far to 6,000.
AutoZone Adds $750 Million to Share Buyback Plan
AutoZone has announced that its board of directors authorized the repurchase of an additional $750 million of the common stock in connection with its ongoing share repurchase program.
Jefferies Identifies 5 Top Biotech Stocks for Huge Upside
Jefferies believes most of the significant biotech downside already occurred, though volatility could continue in the near term.
Why Credit Suisse Sees More Upside in Top Steel Stocks
Credit Suisse has updated its view on U.S. steel companies and where those companies stand to go from here.
How Ionis Pharma Beat a Biotech Giant
Ionis Pharmaceuticals led biotech stocks early on Wednesday following a key patent dispute win in the U.S. court system.
Nike Whiffs on the Top Line Despite Solid Earnings
Nike reported mixed fiscal third-quarter financial results after the markets closed on Tuesday.
Five Below Sinks Despite Earnings Beat
Five Below released a better-than-expected fiscal fourth-quarter earnings report after the markets closed on Tuesday.
3 Analysts Take Positive View on Apple, All for Different Reasons
24/7 Wall St. has come across a few recent analyst calls that all take a positive perspective on the iPhone giant for a few different reasons.
Vivint Solar Secures $200 Million Loan
Vivint Solar announced on Tuesday that it has closed a $200 million loan, just in the past week.
What to Expect From Five Below Earnings
Five Below is set to report its fiscal fourth-quarter financial results after the markets close on Tuesday.
Akorn Back on Track to Restate Results
Akorn reported its preliminary 2015 financial results before the markets opened on Tuesday and issued guidance for the 2016 full year.
Mattress Firm Sinks on Missed Earnings
Mattress Firm reported disappointing fiscal fourth-quarter financial results after the markets closed on Monday.
What to Look for in Nike Earnings
Nike is scheduled to release its fiscal third-quarter financial results after the markets close on Tuesday.
Moleculin Gears Up for IPO
Moleculin Biotech plans to list up to 2 million shares at an estimated $5.50 apiece in an IPO valued at up to $11 million.
Why Key Analyst Sees Major Steel Losing Momentum
While steel prices in the United States may see some near-term upside, one key analyst fears that momentum may run out of steam into summer.
Why Tesla Shares Could Rise Another $100
Argus expects Tesla to meet or exceed its production targets and to achieve positive cash flow in the first quarter of 2016.
Why Investors Still Like Celator Pharma Despite a Loss
Celator Pharmaceuticals reported its fourth-quarter financial results before the markets opened on Monday.
Advaxis Soars on Positive Survival Results
Advaxis made waves in the markets on Monday following the release of positive data from its most recent study.